nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—pancreatitis—pancreatic cancer	0.946	1	CtDrD
Propantheline—Salivation—Irinotecan—pancreatic cancer	0.00115	0.0517	CcSEcCtD
Propantheline—Dermatitis atopic—Gemcitabine—pancreatic cancer	0.000585	0.0264	CcSEcCtD
Propantheline—Thirst—Tamoxifen—pancreatic cancer	0.000481	0.0217	CcSEcCtD
Propantheline—Salivary hypersecretion—Irinotecan—pancreatic cancer	0.000432	0.0195	CcSEcCtD
Propantheline—Dermatitis atopic—Docetaxel—pancreatic cancer	0.000415	0.0187	CcSEcCtD
Propantheline—Dysphagia—Tamoxifen—pancreatic cancer	0.000396	0.0178	CcSEcCtD
Propantheline—Dysphagia—Erlotinib—pancreatic cancer	0.000391	0.0176	CcSEcCtD
Propantheline—Erectile dysfunction—Tamoxifen—pancreatic cancer	0.000364	0.0164	CcSEcCtD
Propantheline—Abdominal distension—Sunitinib—pancreatic cancer	0.000341	0.0154	CcSEcCtD
Propantheline—Dysphagia—Sunitinib—pancreatic cancer	0.000339	0.0153	CcSEcCtD
Propantheline—Flushing—Tamoxifen—pancreatic cancer	0.000294	0.0132	CcSEcCtD
Propantheline—Abdominal distension—Irinotecan—pancreatic cancer	0.000281	0.0127	CcSEcCtD
Propantheline—Dermatitis atopic—Epirubicin—pancreatic cancer	0.00028	0.0126	CcSEcCtD
Propantheline—Dysphagia—Fluorouracil—pancreatic cancer	0.000267	0.012	CcSEcCtD
Propantheline—Dermatitis atopic—Doxorubicin—pancreatic cancer	0.000259	0.0117	CcSEcCtD
Propantheline—Flushing—Sunitinib—pancreatic cancer	0.000252	0.0113	CcSEcCtD
Propantheline—Dry mouth—Tamoxifen—pancreatic cancer	0.000229	0.0103	CcSEcCtD
Propantheline—Flushing—Irinotecan—pancreatic cancer	0.000207	0.00934	CcSEcCtD
Propantheline—Insomnia—Tamoxifen—pancreatic cancer	0.000203	0.00916	CcSEcCtD
Propantheline—Salivary hypersecretion—Epirubicin—pancreatic cancer	0.000201	0.00907	CcSEcCtD
Propantheline—Insomnia—Erlotinib—pancreatic cancer	0.000201	0.00907	CcSEcCtD
Propantheline—Dry mouth—Sunitinib—pancreatic cancer	0.000197	0.00885	CcSEcCtD
Propantheline—Dysphagia—Docetaxel—pancreatic cancer	0.000193	0.00869	CcSEcCtD
Propantheline—Constipation—Tamoxifen—pancreatic cancer	0.000192	0.00867	CcSEcCtD
Propantheline—Constipation—Erlotinib—pancreatic cancer	0.00019	0.00857	CcSEcCtD
Propantheline—Salivary hypersecretion—Doxorubicin—pancreatic cancer	0.000186	0.0084	CcSEcCtD
Propantheline—Urticaria—Tamoxifen—pancreatic cancer	0.000179	0.00805	CcSEcCtD
Propantheline—Vision blurred—Fluorouracil—pancreatic cancer	0.000176	0.00791	CcSEcCtD
Propantheline—Insomnia—Sunitinib—pancreatic cancer	0.000174	0.00785	CcSEcCtD
Propantheline—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000166	0.00747	CcSEcCtD
Propantheline—Constipation—Sunitinib—pancreatic cancer	0.000165	0.00742	CcSEcCtD
Propantheline—Asthenia—Tamoxifen—pancreatic cancer	0.000161	0.00727	CcSEcCtD
Propantheline—Confusional state—Irinotecan—pancreatic cancer	0.00016	0.00721	CcSEcCtD
Propantheline—Asthenia—Erlotinib—pancreatic cancer	0.00016	0.00719	CcSEcCtD
Propantheline—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000159	0.00715	CcSEcCtD
Propantheline—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000155	0.00696	CcSEcCtD
Propantheline—Confusional state—Fluorouracil—pancreatic cancer	0.000153	0.0069	CcSEcCtD
Propantheline—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000152	0.00685	CcSEcCtD
Propantheline—Dizziness—Tamoxifen—pancreatic cancer	0.000149	0.0067	CcSEcCtD
Propantheline—Tachycardia—Fluorouracil—pancreatic cancer	0.000148	0.00668	CcSEcCtD
Propantheline—Dizziness—Erlotinib—pancreatic cancer	0.000147	0.00663	CcSEcCtD
Propantheline—Insomnia—Irinotecan—pancreatic cancer	0.000144	0.00647	CcSEcCtD
Propantheline—Flushing—Docetaxel—pancreatic cancer	0.000143	0.00646	CcSEcCtD
Propantheline—Vomiting—Tamoxifen—pancreatic cancer	0.000143	0.00644	CcSEcCtD
Propantheline—Hypersensitivity—Sunitinib—pancreatic cancer	0.000142	0.00639	CcSEcCtD
Propantheline—Rash—Tamoxifen—pancreatic cancer	0.000142	0.00639	CcSEcCtD
Propantheline—Dermatitis—Tamoxifen—pancreatic cancer	0.000142	0.00638	CcSEcCtD
Propantheline—Vomiting—Erlotinib—pancreatic cancer	0.000141	0.00637	CcSEcCtD
Propantheline—Somnolence—Irinotecan—pancreatic cancer	0.000141	0.00636	CcSEcCtD
Propantheline—Headache—Tamoxifen—pancreatic cancer	0.000141	0.00635	CcSEcCtD
Propantheline—Rash—Erlotinib—pancreatic cancer	0.00014	0.00632	CcSEcCtD
Propantheline—Dermatitis—Erlotinib—pancreatic cancer	0.00014	0.00632	CcSEcCtD
Propantheline—Insomnia—Gemcitabine—pancreatic cancer	0.00014	0.0063	CcSEcCtD
Propantheline—Headache—Erlotinib—pancreatic cancer	0.000139	0.00628	CcSEcCtD
Propantheline—Asthenia—Sunitinib—pancreatic cancer	0.000138	0.00623	CcSEcCtD
Propantheline—Insomnia—Fluorouracil—pancreatic cancer	0.000137	0.00619	CcSEcCtD
Propantheline—Somnolence—Gemcitabine—pancreatic cancer	0.000137	0.00619	CcSEcCtD
Propantheline—Constipation—Irinotecan—pancreatic cancer	0.000136	0.00611	CcSEcCtD
Propantheline—Somnolence—Fluorouracil—pancreatic cancer	0.000135	0.00609	CcSEcCtD
Propantheline—Nausea—Tamoxifen—pancreatic cancer	0.000134	0.00602	CcSEcCtD
Propantheline—Constipation—Gemcitabine—pancreatic cancer	0.000132	0.00595	CcSEcCtD
Propantheline—Nausea—Erlotinib—pancreatic cancer	0.000132	0.00595	CcSEcCtD
Propantheline—Abdominal distension—Epirubicin—pancreatic cancer	0.000131	0.0059	CcSEcCtD
Propantheline—Feeling abnormal—Irinotecan—pancreatic cancer	0.000131	0.00589	CcSEcCtD
Propantheline—Dysphagia—Epirubicin—pancreatic cancer	0.00013	0.00586	CcSEcCtD
Propantheline—Dizziness—Sunitinib—pancreatic cancer	0.000127	0.00574	CcSEcCtD
Propantheline—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000127	0.00574	CcSEcCtD
Propantheline—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000125	0.00564	CcSEcCtD
Propantheline—Vomiting—Sunitinib—pancreatic cancer	0.000122	0.00552	CcSEcCtD
Propantheline—Rash—Sunitinib—pancreatic cancer	0.000121	0.00547	CcSEcCtD
Propantheline—Dermatitis—Sunitinib—pancreatic cancer	0.000121	0.00547	CcSEcCtD
Propantheline—Abdominal distension—Doxorubicin—pancreatic cancer	0.000121	0.00546	CcSEcCtD
Propantheline—Urticaria—Fluorouracil—pancreatic cancer	0.000121	0.00544	CcSEcCtD
Propantheline—Headache—Sunitinib—pancreatic cancer	0.000121	0.00544	CcSEcCtD
Propantheline—Dysphagia—Doxorubicin—pancreatic cancer	0.00012	0.00542	CcSEcCtD
Propantheline—Palpitations—Docetaxel—pancreatic cancer	0.000119	0.00535	CcSEcCtD
Propantheline—Hypersensitivity—Irinotecan—pancreatic cancer	0.000117	0.00527	CcSEcCtD
Propantheline—Drowsiness—Epirubicin—pancreatic cancer	0.000116	0.00523	CcSEcCtD
Propantheline—Nausea—Sunitinib—pancreatic cancer	0.000114	0.00515	CcSEcCtD
Propantheline—Asthenia—Irinotecan—pancreatic cancer	0.000114	0.00513	CcSEcCtD
Propantheline—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000112	0.00504	CcSEcCtD
Propantheline—Dry mouth—Docetaxel—pancreatic cancer	0.000112	0.00504	CcSEcCtD
Propantheline—Asthenia—Gemcitabine—pancreatic cancer	0.000111	0.005	CcSEcCtD
Propantheline—Confusional state—Docetaxel—pancreatic cancer	0.000111	0.00498	CcSEcCtD
Propantheline—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00011	0.00494	CcSEcCtD
Propantheline—Drowsiness—Doxorubicin—pancreatic cancer	0.000107	0.00484	CcSEcCtD
Propantheline—Tachycardia—Docetaxel—pancreatic cancer	0.000107	0.00482	CcSEcCtD
Propantheline—Dizziness—Irinotecan—pancreatic cancer	0.000105	0.00473	CcSEcCtD
Propantheline—Vomiting—Irinotecan—pancreatic cancer	0.000101	0.00455	CcSEcCtD
Propantheline—Dizziness—Fluorouracil—pancreatic cancer	0.000101	0.00453	CcSEcCtD
Propantheline—Rash—Irinotecan—pancreatic cancer	0.0001	0.00451	CcSEcCtD
Propantheline—Dermatitis—Irinotecan—pancreatic cancer	0.0001	0.0045	CcSEcCtD
Propantheline—Headache—Irinotecan—pancreatic cancer	9.94e-05	0.00448	CcSEcCtD
Propantheline—Insomnia—Docetaxel—pancreatic cancer	9.92e-05	0.00447	CcSEcCtD
Propantheline—Vomiting—Gemcitabine—pancreatic cancer	9.83e-05	0.00443	CcSEcCtD
Propantheline—Somnolence—Docetaxel—pancreatic cancer	9.75e-05	0.00439	CcSEcCtD
Propantheline—Rash—Gemcitabine—pancreatic cancer	9.75e-05	0.00439	CcSEcCtD
Propantheline—Dermatitis—Gemcitabine—pancreatic cancer	9.74e-05	0.00439	CcSEcCtD
Propantheline—Headache—Gemcitabine—pancreatic cancer	9.68e-05	0.00436	CcSEcCtD
Propantheline—Flushing—Epirubicin—pancreatic cancer	9.67e-05	0.00435	CcSEcCtD
Propantheline—Vomiting—Fluorouracil—pancreatic cancer	9.66e-05	0.00435	CcSEcCtD
Propantheline—Rash—Fluorouracil—pancreatic cancer	9.58e-05	0.00432	CcSEcCtD
Propantheline—Dermatitis—Fluorouracil—pancreatic cancer	9.57e-05	0.00431	CcSEcCtD
Propantheline—Headache—Fluorouracil—pancreatic cancer	9.52e-05	0.00429	CcSEcCtD
Propantheline—Nausea—Irinotecan—pancreatic cancer	9.43e-05	0.00425	CcSEcCtD
Propantheline—Constipation—Docetaxel—pancreatic cancer	9.38e-05	0.00423	CcSEcCtD
Propantheline—Nausea—Gemcitabine—pancreatic cancer	9.18e-05	0.00414	CcSEcCtD
Propantheline—Feeling abnormal—Docetaxel—pancreatic cancer	9.04e-05	0.00407	CcSEcCtD
Propantheline—Nausea—Fluorouracil—pancreatic cancer	9.03e-05	0.00407	CcSEcCtD
Propantheline—Flushing—Doxorubicin—pancreatic cancer	8.94e-05	0.00403	CcSEcCtD
Propantheline—Tension—Epirubicin—pancreatic cancer	8.9e-05	0.00401	CcSEcCtD
Propantheline—Nervousness—Epirubicin—pancreatic cancer	8.81e-05	0.00397	CcSEcCtD
Propantheline—Vision blurred—Epirubicin—pancreatic cancer	8.54e-05	0.00385	CcSEcCtD
Propantheline—Tension—Doxorubicin—pancreatic cancer	8.23e-05	0.00371	CcSEcCtD
Propantheline—Nervousness—Doxorubicin—pancreatic cancer	8.15e-05	0.00367	CcSEcCtD
Propantheline—Hypersensitivity—Docetaxel—pancreatic cancer	8.08e-05	0.00364	CcSEcCtD
Propantheline—Palpitations—Epirubicin—pancreatic cancer	8.01e-05	0.00361	CcSEcCtD
Propantheline—Vision blurred—Doxorubicin—pancreatic cancer	7.91e-05	0.00356	CcSEcCtD
Propantheline—Asthenia—Docetaxel—pancreatic cancer	7.87e-05	0.00355	CcSEcCtD
Propantheline—Dry mouth—Epirubicin—pancreatic cancer	7.55e-05	0.0034	CcSEcCtD
Propantheline—Confusional state—Epirubicin—pancreatic cancer	7.46e-05	0.00336	CcSEcCtD
Propantheline—Palpitations—Doxorubicin—pancreatic cancer	7.41e-05	0.00334	CcSEcCtD
Propantheline—Anaphylactic shock—Epirubicin—pancreatic cancer	7.4e-05	0.00333	CcSEcCtD
Propantheline—Dizziness—Docetaxel—pancreatic cancer	7.25e-05	0.00327	CcSEcCtD
Propantheline—Tachycardia—Epirubicin—pancreatic cancer	7.22e-05	0.00325	CcSEcCtD
Propantheline—Dry mouth—Doxorubicin—pancreatic cancer	6.98e-05	0.00315	CcSEcCtD
Propantheline—Vomiting—Docetaxel—pancreatic cancer	6.97e-05	0.00314	CcSEcCtD
Propantheline—Rash—Docetaxel—pancreatic cancer	6.92e-05	0.00312	CcSEcCtD
Propantheline—Dermatitis—Docetaxel—pancreatic cancer	6.91e-05	0.00311	CcSEcCtD
Propantheline—Confusional state—Doxorubicin—pancreatic cancer	6.9e-05	0.00311	CcSEcCtD
Propantheline—Headache—Docetaxel—pancreatic cancer	6.87e-05	0.0031	CcSEcCtD
Propantheline—Anaphylactic shock—Doxorubicin—pancreatic cancer	6.85e-05	0.00308	CcSEcCtD
Propantheline—Insomnia—Epirubicin—pancreatic cancer	6.69e-05	0.00301	CcSEcCtD
Propantheline—Tachycardia—Doxorubicin—pancreatic cancer	6.68e-05	0.00301	CcSEcCtD
Propantheline—Somnolence—Epirubicin—pancreatic cancer	6.58e-05	0.00296	CcSEcCtD
Propantheline—Nausea—Docetaxel—pancreatic cancer	6.52e-05	0.00294	CcSEcCtD
Propantheline—Constipation—Epirubicin—pancreatic cancer	6.33e-05	0.00285	CcSEcCtD
Propantheline—Insomnia—Doxorubicin—pancreatic cancer	6.19e-05	0.00279	CcSEcCtD
Propantheline—Feeling abnormal—Epirubicin—pancreatic cancer	6.1e-05	0.00275	CcSEcCtD
Propantheline—Somnolence—Doxorubicin—pancreatic cancer	6.09e-05	0.00274	CcSEcCtD
Propantheline—Urticaria—Epirubicin—pancreatic cancer	5.88e-05	0.00265	CcSEcCtD
Propantheline—Constipation—Doxorubicin—pancreatic cancer	5.85e-05	0.00264	CcSEcCtD
Propantheline—Feeling abnormal—Doxorubicin—pancreatic cancer	5.64e-05	0.00254	CcSEcCtD
Propantheline—Hypersensitivity—Epirubicin—pancreatic cancer	5.45e-05	0.00246	CcSEcCtD
Propantheline—Urticaria—Doxorubicin—pancreatic cancer	5.44e-05	0.00245	CcSEcCtD
Propantheline—Asthenia—Epirubicin—pancreatic cancer	5.31e-05	0.00239	CcSEcCtD
Propantheline—Hypersensitivity—Doxorubicin—pancreatic cancer	5.04e-05	0.00227	CcSEcCtD
Propantheline—Asthenia—Doxorubicin—pancreatic cancer	4.91e-05	0.00221	CcSEcCtD
Propantheline—Dizziness—Epirubicin—pancreatic cancer	4.89e-05	0.0022	CcSEcCtD
Propantheline—Vomiting—Epirubicin—pancreatic cancer	4.7e-05	0.00212	CcSEcCtD
Propantheline—Rash—Epirubicin—pancreatic cancer	4.67e-05	0.0021	CcSEcCtD
Propantheline—Dermatitis—Epirubicin—pancreatic cancer	4.66e-05	0.0021	CcSEcCtD
Propantheline—Headache—Epirubicin—pancreatic cancer	4.64e-05	0.00209	CcSEcCtD
Propantheline—Dizziness—Doxorubicin—pancreatic cancer	4.53e-05	0.00204	CcSEcCtD
Propantheline—Nausea—Epirubicin—pancreatic cancer	4.4e-05	0.00198	CcSEcCtD
Propantheline—Vomiting—Doxorubicin—pancreatic cancer	4.35e-05	0.00196	CcSEcCtD
Propantheline—Rash—Doxorubicin—pancreatic cancer	4.32e-05	0.00194	CcSEcCtD
Propantheline—Dermatitis—Doxorubicin—pancreatic cancer	4.31e-05	0.00194	CcSEcCtD
Propantheline—Headache—Doxorubicin—pancreatic cancer	4.29e-05	0.00193	CcSEcCtD
Propantheline—Nausea—Doxorubicin—pancreatic cancer	4.07e-05	0.00183	CcSEcCtD
Propantheline—CHRM2—Signaling Pathways—GLI1—pancreatic cancer	2.15e-05	0.000679	CbGpPWpGaD
Propantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	2.15e-05	0.000678	CbGpPWpGaD
Propantheline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	2.14e-05	0.000676	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AGTR1—pancreatic cancer	2.14e-05	0.000675	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CNR1—pancreatic cancer	2.13e-05	0.000674	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CNR1—pancreatic cancer	2.13e-05	0.000671	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PPP2R5B—pancreatic cancer	2.12e-05	0.000669	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NRP1—pancreatic cancer	2.12e-05	0.000669	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PPP2R5B—pancreatic cancer	2.11e-05	0.000667	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NRP1—pancreatic cancer	2.11e-05	0.000667	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CNR1—pancreatic cancer	2.1e-05	0.000665	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GLP1R—pancreatic cancer	2.09e-05	0.000661	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PPP2R5B—pancreatic cancer	2.09e-05	0.000661	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NRP1—pancreatic cancer	2.09e-05	0.000661	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—GCG—pancreatic cancer	2.06e-05	0.000651	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—DPYD—pancreatic cancer	2.06e-05	0.00065	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—GCG—pancreatic cancer	2.05e-05	0.000648	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HEY2—pancreatic cancer	2.04e-05	0.000644	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—GCG—pancreatic cancer	2.03e-05	0.000642	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HEY2—pancreatic cancer	2.03e-05	0.000642	CbGpPWpGaD
Propantheline—CHRM1—Circadian rythm related genes—TP53—pancreatic cancer	2.01e-05	0.000636	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HEY2—pancreatic cancer	2.01e-05	0.000636	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—GAST—pancreatic cancer	1.99e-05	0.000629	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—GAST—pancreatic cancer	1.99e-05	0.000627	CbGpPWpGaD
Propantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	1.97e-05	0.000623	CbGpPWpGaD
Propantheline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	1.97e-05	0.000621	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—GAST—pancreatic cancer	1.97e-05	0.000621	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AGTR1—pancreatic cancer	1.96e-05	0.000621	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AGTR1—pancreatic cancer	1.96e-05	0.000619	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—SLC2A2—pancreatic cancer	1.95e-05	0.000617	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AGTR1—pancreatic cancer	1.94e-05	0.000613	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SCT—pancreatic cancer	1.89e-05	0.000596	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HEY1—pancreatic cancer	1.89e-05	0.000596	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SCT—pancreatic cancer	1.88e-05	0.000594	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HEY1—pancreatic cancer	1.88e-05	0.000594	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SCT—pancreatic cancer	1.86e-05	0.000589	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HEY1—pancreatic cancer	1.86e-05	0.000589	CbGpPWpGaD
Propantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	1.83e-05	0.000577	CbGpPWpGaD
Propantheline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	1.82e-05	0.000575	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCK—pancreatic cancer	1.8e-05	0.000569	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCK—pancreatic cancer	1.8e-05	0.000567	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCK—pancreatic cancer	1.78e-05	0.000562	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CNR2—pancreatic cancer	1.76e-05	0.000554	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—GLP1R—pancreatic cancer	1.76e-05	0.000554	CbGpPWpGaD
Propantheline—CHRM1—GPCR ligand binding—CXCL8—pancreatic cancer	1.75e-05	0.000554	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—GLP1R—pancreatic cancer	1.75e-05	0.000553	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CNR2—pancreatic cancer	1.75e-05	0.000553	CbGpPWpGaD
Propantheline—CHRM3—GPCR ligand binding—CXCL8—pancreatic cancer	1.75e-05	0.000552	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CNR2—pancreatic cancer	1.73e-05	0.000547	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—GLP1R—pancreatic cancer	1.73e-05	0.000547	CbGpPWpGaD
Propantheline—CHRM2—GPCR ligand binding—CXCL8—pancreatic cancer	1.73e-05	0.000547	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCKAR—pancreatic cancer	1.73e-05	0.000545	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCKAR—pancreatic cancer	1.72e-05	0.000544	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCKAR—pancreatic cancer	1.7e-05	0.000538	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—JAG2—pancreatic cancer	1.67e-05	0.000529	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—JAG2—pancreatic cancer	1.67e-05	0.000527	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—JAG2—pancreatic cancer	1.65e-05	0.000522	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MEN1—pancreatic cancer	1.65e-05	0.000521	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MEN1—pancreatic cancer	1.64e-05	0.00052	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MEN1—pancreatic cancer	1.63e-05	0.000515	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SHH—pancreatic cancer	1.57e-05	0.000497	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SHH—pancreatic cancer	1.57e-05	0.000496	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NOTCH4—pancreatic cancer	1.56e-05	0.000494	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NOTCH4—pancreatic cancer	1.56e-05	0.000493	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IAPP—pancreatic cancer	1.55e-05	0.000491	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SHH—pancreatic cancer	1.55e-05	0.000491	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IAPP—pancreatic cancer	1.55e-05	0.00049	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NOTCH4—pancreatic cancer	1.54e-05	0.000488	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IAPP—pancreatic cancer	1.53e-05	0.000485	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CD44—pancreatic cancer	1.51e-05	0.000478	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PTHLH—pancreatic cancer	1.49e-05	0.000471	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PTCH1—pancreatic cancer	1.49e-05	0.000471	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PTHLH—pancreatic cancer	1.49e-05	0.00047	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PTCH1—pancreatic cancer	1.49e-05	0.00047	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PTCH1—pancreatic cancer	1.47e-05	0.000465	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PTHLH—pancreatic cancer	1.47e-05	0.000465	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GCG—pancreatic cancer	1.45e-05	0.000458	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SST—pancreatic cancer	1.36e-05	0.000431	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—STK11—pancreatic cancer	1.36e-05	0.000431	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SST—pancreatic cancer	1.36e-05	0.00043	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SST—pancreatic cancer	1.35e-05	0.000426	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.35e-05	0.000425	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.34e-05	0.000424	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—JAG1—pancreatic cancer	1.34e-05	0.000422	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—JAG1—pancreatic cancer	1.33e-05	0.000421	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NOTCH3—pancreatic cancer	1.33e-05	0.00042	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.33e-05	0.00042	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NOTCH3—pancreatic cancer	1.33e-05	0.000419	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	1.32e-05	0.000417	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	1.31e-05	0.000415	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CNR1—pancreatic cancer	1.26e-05	0.000398	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	1.26e-05	0.000397	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	1.24e-05	0.000393	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	1.22e-05	0.000386	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	1.22e-05	0.000385	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—GCG—pancreatic cancer	1.22e-05	0.000384	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—GCG—pancreatic cancer	1.21e-05	0.000383	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	1.21e-05	0.000381	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—GCG—pancreatic cancer	1.2e-05	0.000379	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.18e-05	0.000374	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.18e-05	0.000373	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—TYMS—pancreatic cancer	1.17e-05	0.000371	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.17e-05	0.000369	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AGTR1—pancreatic cancer	1.16e-05	0.000367	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	1.16e-05	0.000365	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	1.15e-05	0.000362	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—STK11—pancreatic cancer	1.14e-05	0.000361	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—STK11—pancreatic cancer	1.14e-05	0.00036	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—STK11—pancreatic cancer	1.13e-05	0.000357	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	1.07e-05	0.000339	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	1.07e-05	0.000338	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.06e-05	0.000335	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.03e-05	0.000326	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.03e-05	0.000325	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.02e-05	0.000322	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	1e-05	0.000316	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	9.99e-06	0.000315	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	9.91e-06	0.000313	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	9.89e-06	0.000312	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	9.88e-06	0.000312	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	9.79e-06	0.000309	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HES1—pancreatic cancer	9.78e-06	0.000309	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HES1—pancreatic cancer	9.75e-06	0.000308	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HES1—pancreatic cancer	9.66e-06	0.000305	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOE—pancreatic cancer	9.54e-06	0.000301	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	9.37e-06	0.000296	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	9.34e-06	0.000295	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	9.25e-06	0.000292	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	9e-06	0.000284	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	8.97e-06	0.000283	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	8.89e-06	0.000281	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CG—pancreatic cancer	8.61e-06	0.000272	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TERT—pancreatic cancer	8.57e-06	0.000271	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TERT—pancreatic cancer	8.54e-06	0.00027	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TERT—pancreatic cancer	8.46e-06	0.000267	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PPARG—pancreatic cancer	8.31e-06	0.000262	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	8.2e-06	0.000259	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	8.18e-06	0.000258	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	8.17e-06	0.000258	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	8.15e-06	0.000257	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	8.09e-06	0.000256	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	8.07e-06	0.000255	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOE—pancreatic cancer	8e-06	0.000253	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOE—pancreatic cancer	7.98e-06	0.000252	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOE—pancreatic cancer	7.9e-06	0.00025	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KDR—pancreatic cancer	7.84e-06	0.000248	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KDR—pancreatic cancer	7.81e-06	0.000247	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KDR—pancreatic cancer	7.74e-06	0.000244	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CD—pancreatic cancer	7.57e-06	0.000239	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	7.46e-06	0.000236	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	7.43e-06	0.000235	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	7.38e-06	0.000233	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	7.36e-06	0.000233	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	7.36e-06	0.000233	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	7.29e-06	0.00023	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	7.22e-06	0.000228	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	7.22e-06	0.000228	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	7.2e-06	0.000227	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	7.2e-06	0.000227	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EGF—pancreatic cancer	7.14e-06	0.000225	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	7.13e-06	0.000225	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	7.13e-06	0.000225	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EGF—pancreatic cancer	7.12e-06	0.000225	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EGF—pancreatic cancer	7.05e-06	0.000223	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CB—pancreatic cancer	6.6e-06	0.000208	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	6.58e-06	0.000208	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	6.56e-06	0.000207	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PTGS2—pancreatic cancer	6.54e-06	0.000206	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	6.49e-06	0.000205	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	6.35e-06	0.000201	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	6.33e-06	0.0002	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.29e-06	0.000199	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.27e-06	0.000198	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	6.27e-06	0.000198	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	6.22e-06	0.000196	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.21e-06	0.000196	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	6.2e-06	0.000196	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	6.14e-06	0.000194	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	5.71e-06	0.00018	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PTEN—pancreatic cancer	5.7e-06	0.00018	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	5.69e-06	0.00018	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	5.64e-06	0.000178	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	5.53e-06	0.000175	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	5.52e-06	0.000174	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	5.46e-06	0.000173	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	5.32e-06	0.000168	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	5.3e-06	0.000167	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	5.28e-06	0.000167	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	5.27e-06	0.000166	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	5.25e-06	0.000166	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	5.22e-06	0.000165	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	5.14e-06	0.000162	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	5.12e-06	0.000162	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	5.09e-06	0.000161	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	5.07e-06	0.00016	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	5.07e-06	0.00016	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	5.02e-06	0.000159	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	4.95e-06	0.000156	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	4.94e-06	0.000156	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	4.91e-06	0.000155	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	4.89e-06	0.000154	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	4.89e-06	0.000154	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	4.84e-06	0.000153	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	4.81e-06	0.000152	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	4.79e-06	0.000151	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	4.78e-06	0.000151	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	4.77e-06	0.000151	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	4.75e-06	0.00015	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	4.72e-06	0.000149	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	4.66e-06	0.000147	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	4.65e-06	0.000147	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	4.6e-06	0.000145	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SRC—pancreatic cancer	4.43e-06	0.00014	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SRC—pancreatic cancer	4.42e-06	0.00014	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SRC—pancreatic cancer	4.38e-06	0.000138	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	4.32e-06	0.000136	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	4.31e-06	0.000136	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	4.28e-06	0.000135	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	4.27e-06	0.000135	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	4.26e-06	0.000135	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	4.26e-06	0.000135	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	4.25e-06	0.000134	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	4.22e-06	0.000133	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	4.21e-06	0.000133	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CA—pancreatic cancer	4.02e-06	0.000127	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MYC—pancreatic cancer	3.97e-06	0.000126	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	3.96e-06	0.000125	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MYC—pancreatic cancer	3.96e-06	0.000125	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	3.95e-06	0.000125	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MYC—pancreatic cancer	3.92e-06	0.000124	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	3.91e-06	0.000124	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	3.89e-06	0.000123	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	3.87e-06	0.000122	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	3.84e-06	0.000121	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	3.67e-06	0.000116	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	3.66e-06	0.000116	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	3.62e-06	0.000114	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	3.37e-06	0.000107	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	3.36e-06	0.000106	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	3.33e-06	0.000105	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AKT1—pancreatic cancer	3.29e-06	0.000104	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TP53—pancreatic cancer	3.26e-06	0.000103	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TP53—pancreatic cancer	3.25e-06	0.000103	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TP53—pancreatic cancer	3.22e-06	0.000102	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	3.12e-06	9.86e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	3.11e-06	9.83e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	3.08e-06	9.73e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	2.76e-06	8.71e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	2.75e-06	8.68e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	2.72e-06	8.59e-05	CbGpPWpGaD
